Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2015-09-30
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Deep Neuromuscular Blockade on Intraoperative Respiratory Mechanics
NCT02185339
Hemodynamic and Respiratory Variations During Laparoscopic Surgery With and Without Deep Neuromuscular Blockade.
NCT02025075
Effect of Magnesium on Dose of Rocuronium for Deep Neuromuscular Blockade
NCT04013243
Preemptive Analgesic Effects of Rectus Sheath Block in Laparoscopic Cholecystectomy Patients
NCT03413280
Bilateral Dual Transversus Abdominis Plane Block for Robotic Assisted Laparoscopic Surgery
NCT01760161
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Moderate block (MB) group
Rocuronium (MB group)
Count of train-of-four: 1-2 Titration of rocuronium dose
Deep block (DB) group
Rocuronium (DB group)
Post-tetanic count: 1-2 Titration of rocuronium dose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rocuronium (MB group)
Count of train-of-four: 1-2 Titration of rocuronium dose
Rocuronium (DB group)
Post-tetanic count: 1-2 Titration of rocuronium dose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologist physical status 1 or 2
Exclusion Criteria
* Body mass index \< 16
* Body mass index \>30
* Neuromuscular disease
* Previous intraabdominal surgery
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hyo-Seok Na
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hyo-Seok Na
Role: PRINCIPAL_INVESTIGATOR
82, Gumi 173
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ADMS NMD depth
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.